Association between somatic RET mutations and clinical and genetic characteristics in patients with metastatic colorectal cancer.

Our study suggests that cases with RET mutations represent a separate mCRC subtype. Further studies are needed to evaluate the efficacy of RET inhibitors in mCRC patients with RET mutations.